Review: Taurine: A "very essential" amino acid

Molecular Vision

Volumn 18, Issue , 2012, Pages 2673-2686

  Ripps, Harris ^a,b   Shen, Wen ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CARBOXYLYASE; CREATINE; CYSTEINE; CYSTEINESULFINIC ACID DECARBOXYLASE; CYTOCHROME C; GAUNIDINOETHYL SULFONIC ACID; METHIONINE; PROTEIN BAX; PROTEIN BCL 2; SEROTONIN; SULFONIC ACID DERIVATIVE; TAURINE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; BRAIN DEVELOPMENT; BRAIN REGION; CELL PROTECTION; CHEMICAL STRUCTURE; CILIARY BODY; CORNEA; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; EPILEPSY; EXPERIMENTAL STUDY; EYE DEVELOPMENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; IRIS; KIDNEY FUNCTION; LENS; NERVE DEGENERATION; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RETINA; RETINAL NEURODEGENERATION; REVIEW; VITREOUS BODY;

AMINO ACIDS, ESSENTIAL; ANIMALS; BRAIN; CILIARY BODY; CORNEA; CYTOPROTECTION; DIABETES MELLITUS; EPILEPSY; HUMANS; IRIS; LENS, CRYSTALLINE; NEURONS; RETINA; TAURINE;

EID: 84870002886     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Review

References (171)

1. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164:719-21.[PMID: 5778021].
2. Olney JW. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 1969; 28:455-74.[PMID: 5788942].
3. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970; 227:609-11.[PMID: 5464249].
4. Balcar VJ, Johnston GAR. Glutamate uptake by brain slices and its relation to the depolarization of neurons by acidic amino acids. J Neurobiol 1972; 3:295-301.[PMID: 5087156].
5. Schousboe A, Hertz L. Role of astroglial cells in glutamate homeostasis. Adv Biochem Psychopharmacol 1981; 27:103-13.[PMID: 7446271].
6. Fonnum F. Glutamate: a neurotransmitter in the mammalian brain. J Neurochem 1984; 42:1-11.[PMID: 6139418].
7. Hamberger AC, Chiang GH, Nylen ES, Scheff SW, Cotman CW. Glutamate as a CNS transmitter. 1. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res 1979; 168:513-30.[PMID: 435980].
8. Shank RP, Aprison MH. Present status and significance of the glutamine cycle in neural tissue. Life Sci 1981; 28:837-[PMID: 6111730].
9. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994; 35:907-15.[PMID: 8125754].
10. LaVail MM, Yasumura D, Matthes MT, Lau-Villacorta C, Unoki K, Sung CH, Steinberg RH. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39:592-602.[PMID: 9501871].
11. Cao W, Li F, Steinberg RH, Lavail MM. Development of normal and injury-induced gene expression of aFGF, bFGF, CNTF, BDNF, GFAP and IGF-I in the rat retina. Exp Eye Res 2001; 72:591-604.[PMID: 11311051].
12. Paskowitz DM, Donohue-Rolfe KM, Yang H, Yasumura D, Matthes MT, Hosseini K, Graybeal CM, Nune G, Zarbin MA, Lavail MM, Duncan JL. Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy. Invest Ophthalmol Vis Sci 2007; 48:430-7.[PMID: 17197564].
13. Wen R, Song Y, Matthes MT, Yasumura D, LaVail MM, Steinberg RH. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J Neuroscience 1995; 15:7377-85.[PMID: 7472491].
14. Sanz MM, Johnson LE, Ahuja S, Ekstrom PAR, Romero J, VanVeen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neurosci. 2007; 145:1120-9.[PMID: 17293057].
15. Lombardini JB. Effects of ATP and taurine on calcium uptake by membrane preparations of the rat retina. J Neurochem 1983; 40:402-6.[PMID: 6822830].
16. Voss JW, Pedersen SF, Christensen ST, Lambert IH. Regulation of the expression and subcellular localization of the taurine transporter TauT in mouse NIH3T3 fibroblasts. Eur J Biochem 2004; 271:4646-58.[PMID: 15606752].
17. Tiedemann F, Gmelin L. Einige neue Bestandteile der Galle des Ochsen. Ann Physik Chem. 1827; 9:326-37.
18. Demarcay H. Uber die Natur der Galle. Ann Pharmazie. 1838; 27:270-91.
19. Stipanuk MH. Metabolism of sulfur-containing amino acids. Annu Rev Nutr 1986; 6:179-209.[PMID: 3524616].
20. Reymond I, Sergeant A, Tappaz M. Molecular cloning and sequence analysis of the cDNA encoding rat liver cysteine sulfinate decarboxylase (CSD). Biochim Biophys Acta 1996; 1307:152-6.[PMID: 8679699].
21. Shinwell ED, Gorodischer R. Totally vegetarian diets and infant nutrition. Pediatrics 1982; 70:582-6.[PMID: 6812012].
22. Klein DC, Wheler GH, Weller JL. Taurine in the pineal gland. Prog Clin Biol Res 1983; 125:169-81.[PMID: 6308680].
23. Omura Y, Hach A, Furukawa E, Ueck M, Lake N. Immunocytochemical localization of taurine in the pineal organ and retina of an anadromous fish, Plecoglossus altivelis. Arch Histol Cytol 1997; 60:153-62.[PMID: 9232179].
24. Agrawal HC, Davison AN, Kaczmarek LK. Subcellular distribution of taurine and cysteinsulphinate decarboxylase in developing rat brain. Biochem J 1971; 122:759-63.[PMID: 5129271].
25. Junyent F, De Lemos L, Utrera J, Paco S, Aguado F, Camins A, Pallàs M, Romero R, Auladell C. Content and traffic of taurine in hippocampal reactive astrocytes. Hippocampus 2011; 21:185-97.[PMID: 20082296].
26. Fordahl SC, Anderson JG, Cooney PT, Weaver TL, Colyer CL, Erikson KM. Manganese exposure inhibits the clearance of extracellular GABA and influences taurine homeostasis in the striatum of developing rats. Neurotoxicology 2010; 31:639-46.[PMID: 20832424].
27. Chan-Palay V, Lin C-T, Palay S, Yamamoto M, Wu J-Y. Taurine in the mammalian cerebellum: demonstration by autoradiography with [3H]taurine and immunocyto- chemistry with antibodies against the taurine- synthesizing enzyme, cysteine-sulfinic acid decarboxylase. Proc Natl Acad Sci USA 1982; 79:2695-9.[PMID: 6953423].
28. Taranukhin AG, Taranukhina EY, Saransaari P, Podkletnova IM, Pelto-Huikko M, Oja SS. Neuroprotection by taurine in ethanol-induced apoptosis in the developing cerebellum. J Biomed Sci. 2010; 24; Suppl 1:S12, 11 pp.
29. Wu JY, Tang XW, Schloss JV, Faiman MD. Regulation of taurine biosynthesis and its physiological significance in the brain. Adv Exp Med Biol 1998; 442:339-45.[PMID: 9635049].
30. Wu JY, Wu H, Jin Y, Wei J, Sha D, Prentice H, Lee HH, Lin CH, Lee YH, Yang LL. Mechanism of neuroprotective function of taurine. Adv Exp Med Biol 2009; 643:169-79.[PMID: 19239147].
31. Sturman JA, Gaull GE. Taurine in the brain and liver of the developing human and monkey. J Neurochem 1975; 25:831-5.[PMID: 812959].
32. Sturman JA, Hayes KC. The biology of taurine in nutrition and development. Adv Nutr Res 1980; 3:231-99.
33. Zulli A. Taurine in cardiovascular disease. Curr Opin Clin Nutr Metab Care 2011; 14:57-60.[PMID: 21076292].
34. Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci 2010; 17:Suppl 1S6-[PMID: 20804626].
35. L'Amoreaux WJ, Cuttitta C, Santora A, Blaize JF, Tachjadi J, El Idrissi A. Taurine regulates insulin release from pancreatic beta cell lines. J Biomed Sci 2010; 17:Suppl 1S11-[PMID: 20804585].
36. Schmidt SY, Berson EL, Hayes KC. Retinal degeneration in cats fed casein. I. Taurine deficiency. Invest Ophthalmol 1976; 15:47-52.[PMID: 1245381].
37. Pasantes-Morales H, Ademe RM, Quesada O. Protective effect of taurine on the light-induced disruption of isolated frog rod outer segments. J Neurosci Res 1981; 6:337-48.[PMID: 6271986].
38. Pasantes-Morales H, Cruz C. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res 1985; 330:154-7.[PMID: 3986537].
39. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH. Taurine ameliorates chronic streptozotocin-induced diabetic neuropathy in rats. Am J Physiol 1995; 269:F429-38.[PMID: 7573492].
40. Anuradha CV, Balakrishnan SD. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 1999; 77:749-54.[PMID: 10588478].
41. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 2000; 71:54-8.[PMID: 10617946].
42. Nandhini AT, Anuradha CV. Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids 2002; 22:27-38.[PMID: 12025872].
43. Haber CA, Lam TKT, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 2003; 285:E744-53.[PMID: 12799318].
44. Franconi F, Di Leo MAS, Bennardini F, Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 2004; 29:143-50.[PMID: 14992273].
45. Franconi F, Loizzo A, Ghirlanda G, Seghieri G. Taurine supplementation and diabetes mellitus. Curr Opin Nutr Metab 2006; 9:32-6.[PMID: 16444816].
46. De la Puerta C, Arrieta FJ, Balsa JA, Botella-Carretero JI, Zamarrón I, Vázquez C. Taurine and glucose metabolism. Nutr Hosp 2010; 25:910-9.[PMID: 21519760].
47. Ito T, Schaffer SW, Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 2012; 42:1529-39.[PMID: 21437784].
48. Wu QD, Wang JH, Fennessy F, Redmond HP. Bouchier-Hayes. Taurine prevents high glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 1999; 277:C1299-1238.
49. Nandhini AT. Thirunavukkarasu, Anuradha CV. Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 2005; 31:337-44.[PMID: 16369195].
50. Schmetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, Adam H, Eichler HG, Wolzt M. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 1997; 46:653-8.[PMID: 9075807].
51. Bridges CC, Ola MS, Prasad PD, El-Sherbeny A, Ganapathy V, Smith SB. Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. Am J Physiol Cell Physiol 2001; 281:C1825-36.[PMID: 11698241].
52. Chesney RW, Han X, Patters AB. Taurine and the renal system. J Biomed Sci 2010; 17:Suppl 1S4-[PMID: 20804616].
53. Kulakowski EC, Maturo J. Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 1984; 33:2835-8.[PMID: 6383406].
54. Brøns C, Spohr C, Storgaard H, Dyerberg J, Vaag A. Effect of taurine treatment on insulin secretion and action,and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 2004; 58:1239-47.[PMID: 15054439].
55. van Gelder NM, Koyama I, Jasper HH. Taurine treatment of spontaneous chronic epilepsy in a cat. Epilepsia 1977; 18:45-54.[PMID: 404139].
56. Carruthers-Jones DI, van Gelder NM. Influence of taurine dosage on cobalt epilepsy in mice. Neurochem Res 1978; 3:115-23.[PMID: 683411].
57. Izumi K, Donaldson J, Minnich JL, Barbeau A. Ouabain-induced seizures in rats: suppressive effects of taurine and gamma-aminobutyric acid. Can J Physiol Pharmacol 1973; 51:885-9.[PMID: 4777238].
58. Hayashi T. The inhibitory action of beta-hydroxy-gamma-aminobutyric acid upon the seizure following stimulation of the motor cortex of the dog. J Physiol 1959; 145:570-8.[PMID: 13642322].
59. Barbeau A, Donaldson J. Zinc, taurine, and epilepsy. Arch Neurol 1974; 30:52-8.[PMID: 4271319].
60. Gupta RC, Win T, Bittner S. Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem 2005; 12:2021-39.[PMID: 16101502].
61. Reddy DVN. Distribution of free amino acids and related compounds in ocular fluids, lens, and plasma of various mammalian species. Invest Ophthalmol 1967; 6:478-83.[PMID: 4964822].
62. Reddy VN. Studies on intraocular transport of taurine. II. Accumulation in the rabbit lens. Invest Ophthalmol 1970; 9:206-19.[PMID: 5416397].
63. Pourcho RG. Distribution of [35S] taurine in mouse retina after intravitreal and intravascular injection. Exp Eye Res 1977; 25:119-27.[PMID: 913504].
64. Lake N, Verdone-Smith C. Immunocytochemical localization of taurine in mammalian retina. Curr Eye Res 1989; 8:163-73.[PMID: 2714101].
65. Omura Y, Inagaki M. Immunocytochemical localization of taurine in the fish retina under light and dark adaptations. Amino Acids 2000; 19:593-604.[PMID: 11140362].
66. Nusetti S, Salazar V. Lima L. Localization of taurine transporter, taurine, and zinc in goldfish retina. Adv Exp Med Biol 2009; 643:233-42.[PMID: 19239154].
67. Heinämäki AA, Muhonen AS, Piha RS. Taurine and other free amino acids in the retina, vitreous, lens, iris-ciliary body, and cornea of the rat eye. Neurochem Res 1986; 11:535-42.[PMID: 3724960].
68. Cohen AI, McDaniel M, Orr H. Absolute levels of some free amino acids in normal and biologically fractionated retinas. Invest Ophthalmol 1973; 12:686-93.[PMID: 4742064].
69. Hayes KC, Rabin AR, Berson EL. An ultrastructural study of nutritionally induced and reversed retinal degeneration in cats. Am J Pathol 1975; a78:505-24.[PMID: 1119539].
70. Hayes KC, Carey RE, Schmidt SY. Retinal degeneration associated with taurine deficiency in the cat. Science 1975; b188:949-51.[PMID: 1138364].
71. Berson EL, Hayes KC, Rabin AR, Schmidt SY, Watson G. Retinal degeneration in cats fed casein. II Supplementation with methionine, cysteine, or taurine. Invest Ophthalmol 1976; 15:52-8.[PMID: 1245382].
72. Pasantes-Morales H, Domínguez L, Campomanes MA, Pacheco P. Retinal degeneration induced by taurine deficiency in light-deprived cats. Exp Eye Res 1986; 43:55-60.[PMID: 3732417].
73. Rapp LM, Thum LA, Tarver AP, Wiegand RD. Retinal changes associated with taurine depletion in pigmented rats. In: Degenerated retinal disorders: Clinical and Laboratory Investigations, Alan R. Liss, Inc., 1987; pp 485-495.
74. Imaki H, Jacobson SG, Kemp CM, Knighton RW, Neuringer M, Sturman J. Retinal morphology and visual pigment levels in 6- and 12-month-old rhesus monkeys fed a taurine-free human infant formula. J Neurosci Res 1993; 36:290-304.[PMID: 8271309].
75. Gaucher D, Arnault E, Husson Z, Froger N, Dubus E, Gondouin P, Dherbécourt D, Degardin J, Simonutti M, Fouquet S, Benahmed MA, Elbayed K, Namer IJ, Massin P, Sahel JA, Picaud S. Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids 2012; Epub ahead of print[PMID: 22476345].
76. Vinnakota S, Qian X, Egal H, Sarthy V, Sarkar HK. Molecular characterization and in situ localization of a mouse retinal taurine transporter. J Neurochem 1997; 69:2238-50.[PMID: 9375654].
77. 2+-dependent pathways in retinal third-order neurons. J Biomed Sci 2010; 17:Suppl 1S5-[PMID: 20804625].
78. Lambert IH. Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem Res 2004; 29:27-63.[PMID: 14992263].
79. Smith KE, Borden LA, Wang CH, Hartig PR, Branchek TA, Weinshank RL. Cloning and expression of a high affinity taurine transporter from rat brain. Mol Pharmacol 1992; 42:563-9.[PMID: 1435737].
80. Lill H, Nelson N. Homologies and family relationships among Na+/Cl- neurotransmitter transporters. Methods Enzymol 1998; 296:425-36.[PMID: 9779464].
81. Sivakami S, Ganapathy V, Leibach FH, Miyamoto Y. The γ-aminobutyric acid transporter and its interaction with taurine in the apical membrane of the bovine retinal pigment epithelium. Biochem J 1992; 283:391-7.[PMID: 1575683].
82. Lake N. Electroretinographic deficits in rats treated with guanidinoethyl sulfonate, a depletor of taurine. Exp Eye Res 1986; 42:87-91.[PMID: 3956606].
83. Lake N, Malik N. Retinal morphology in rats treated with a taurine transport antagonist. Exp Eye Res 1987; 44:331-46.[PMID: 3595755].
84. Shimada C, Tanaka S, Hasegawa M, Kuroda S, Isaka K, Sano M, Araki H. Beneficial effect of intravenous taurine infusion on electroretinographic disorder in taurine deficient rats. Jpn J Pharmacol 1992; 59:43-50.[PMID: 1507656].
85. Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D. Disruption of the taurine transporter gene (taut) leads to retinal generation in mice. FASEB J 2002; 16:231-3.[PMID: 11772953].
86. Ehinger B. Glial uptake of taurine in the rabbit retina. Brain Res 1973; 60:512-6.[PMID: 4357897].
87. Pasantes-Morales H, Klethi J, Urban PF, Mandel P. The physiological role of taurine in retina: uptake and effect on electroretinogram (ERG). Physiol Chem Phys 1972; 4:339-48.[PMID: 4156806].
88. Kennedy AJ, Voaden MJ. Studies on the uptake and release of radioactive taurine by the frog retina. J Neurochem 1976; 27:131-7.[PMID: 1085346].
89. Orr HT. Cohen Al, Lowry OH. The distribution of taurine in the vertebrate retina. J Neurochem 1976; 26:609-11.[PMID: 816997].
90. Lake N, Marshall J, Voaden MJ. High affinity uptake sites for taurine in the retina. Exp Eye Res 1978; 27:713-8.[PMID: 104877].
91. Pow DV, Crook DK. Rapid postmortem changes in the cellular localisation of amino acid transmitters in the retina as assessed by immunocytochemistry. Brain Res 1994; 653:199-209.[PMID: 7982053].
92. Miller S, Steinberg RH. Transport of taurine, L-methionine and 3- o-methyl-D-glucose across frog retinal pigment epithelium. Exp Eye Res 1976; 23:177-89.[PMID: 1086253].
93. Ostwald TJ, Steinberg RH. Transmembrane components of taurine flux across frog retinal pigment epithelium. Curr Eye Res 1981; 1:437-43.[PMID: 6977432].
94. Törnquist P, Alm A. Carrier-mediated transport of amino acids through the blood-retinal and the blood-brain barriers. Graefes Arch Clin Exp Ophthalmol 1986; 224:21-5.[PMID: 3943730].
95. Hillenkamp J, Hussain AA, Jackson TL, Cunningham JR, Marshall J. The influence of path length and matrix components on ageing characteristics of transport between the choroid and the outer retina. Invest Ophthalmol Vis Sci 2004; 45:1493-8.[PMID: 15111607].
96. Wu H, Jin Y, Wei J, Jin H, Sha D, Wu JY. Mode of action of taurine as a neuroprotector. Brain Res 2005; 1038:123-31.[PMID: 15757628].
97. Foos TM, Wu JY. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 2002; 27:21-6.[PMID: 11926272].
98. Leon R, Wu H, Jin Y, Wei J, Buddhala C, Prentice H, Wu J-Y. Protective function of taurine in glutamate- induced apoptosis in cultured neurons. J Neurosci Res 2009; 87:1185-94.[PMID: 18951478].
99. Sun M, Xu C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol Neurobiol 2008; 28:593-611.[PMID: 17712625].
100. Kontro P, Oja SS. Interaction of taurine with GABAB binding sites in mouse brain. Neuropharmacol. 1990; 29:243-7.
101. Smith SS, Li J. GABAB receptor stimulation by baclofen and taurine enhances excitatory amino acid induced phosphatidylinositol turnover in neonatal rat cerebellum. Neurosci Lett 1991; 132:59-64.[PMID: 1686306].
102. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53:5274-83.[PMID: 8221662].
103. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996; 93:1831-5.[PMID: 8700844].
104. Krysko DV, Leybaert L, Vandenabeele P, D'Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 2005; 10:459-69.[PMID: 15909108].
105. Hudspeth AJ, Yee AG. The intercellular junctional complexes of retinal pigment epithelia. Invest Ophthalmol 1973; 12:354-65.[PMID: 4196691].
106. Udawatte C, Qian H, Mangini NJ, Kennedy BG, Ripps H. Taurine suppresses the spread of cell death in electrically coupled RPE cells. Mol Vis 2008; 14:1940-50.[PMID: 18958305].
107. Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y, Azuma J. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol 2004; 287:C949-53.[PMID: 15253891].
108. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyophathy with cardiac atrophy. J Mol Cell Cardiol 2008; 44:927-37.[PMID: 18407290].
109. Sturman JA, Moretz RC, French JH, Wisniewski HM. Taurine deficiency in the developing cat: persistence of the cerebellar external granule layer. J Neurosci Res 1985; a13:405-16.[PMID: 3989883].
110. Sturman JA, Moretz RC, French JH, Wisniewski HM. Postnatal taurine deficiency in the kitten results in a persistence of the cerebellar external granule cell layer: correction by taurine feeding. J Neurosci Res 1985; b13:521-8.[PMID: 4040176].
111. Palackal T, Moretz R, Wisniewski H, Sturman J. Abnormal visual cortex development in the kitter associated with maternal dietary taurine deprivation. J Neurosci Res 1986; 15:223-39.[PMID: 2421007].
112. Neuringer M, Palackal T, Kujawa M, Moretz RC, Sturman JA. Visual cortex develoment in rhesus monkeys deprived of dietary taurine. Prog Clin Biol Res 1990; 351:415-22.[PMID: 2236147].
113. Maar T, Moran J, Schousboe A, Pasantes-Morales H. Taurine deficiency in dissociated mouse cerebellar cultures affects neuronal migration. Int J Dev Neurosci 1995; 13:491-502.[PMID: 7484220].
114. Hernández-Benítez R, Pasantes-Morales H, Saldaña IT, Ramos-Mandujano G. Taurine stimulates proliferation of mice embryonic cultured neural progenitor cells. J Neurosci Res 2010; 88:1673-81.[PMID: 20029963].
115. Hernández-Benítez R, Ramos-Mandujano G, Pasantes-Morales H. Taurine stimulates proliferation and promotes neurogenesis of mouse adult cultured neural stem/progenitor cells. Stem Cell Res 2012; 9:24-34.[PMID: 22484511].
116. Sturman JA, Gargano AD, Messing JM, Imaki H. Feline maternal taurine deficiency: effect on mother and offspring. J Nutr 1986; 116:655-67.[PMID: 3754276].
117. Imaki H, Moretz RC, Wisniewski HM, Sturma JA. Feline maternal taurine deficiency: effects on retina and tapetum of the offspring. Dev Neurosci 1986; 8:160-81.[PMID: 3769817].
118. Lake N. Depletion of retinal taurine by treatment with guanidoethyl sulfonate. Life Sci 1981; 29:445-8.[PMID: 7278495].
119. Lake N. Taurine depletion leads to loss of rat optic axons. Vision Res 1988; 28:1071-6.[PMID: 3257010].
120. Altshuler D, Lo Turco JJ, Rush J, Cepko C. Taurine promotes the differentiation of a vertebrate retinal cell type in vitro. Development 1993; 119:1317-28.[PMID: 8306890].
121. Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL. Characterization of mice with targeted deletion of glycine receptor alpha 2. Mol Cell Biol 2006; 26:5728-34.[PMID: 16847326].
122. Young TL, Matsuda T, Cepko CL. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol 2005; 15:501-12.[PMID: 15797018].
123. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, Akaike A, Sasai Y, Takahashi M. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26:215-24.[PMID: 18246062].
124. Young TL, Cepko CL. A role for ligand-gated ion channels in rod photoreceptor development. Neuron 2004; 41:867-79.[PMID: 15046720].
125. Rentería RC, Johnson JDR. Copenhagen, D. R. Need rods? Get glycine receptors and taurine. Neuron 2004; 41:839-41.[PMID: 15046714].
126. Chen G, Nan C, Tian J, Jean-Charles P, Li Y, Weissbach H, Huang XP. Protective effects of taurine against oxidative stress in the heart of MsrA knockout mice. J Cell Biochem 2012; 113:3559-66.[PMID: 22740506].
127. Das J, Sil PC. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 2012; Epub ahead of print[PMID: 22302365].
128. Marcinkiewicz J, Kontny E. Taurine and inflammatory diseases. Amino Acids 2012; Epub ahead of print[PMID: 22810731].
129. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 1988; 256:251-5.[PMID: 2851980].
130. Crompton M, Andreeva L. On the involvement of mitochondrial pore in reperfusion injury. Basic Res Cardiol 1993; 88:513-23.[PMID: 8117255].
131. DiMonte DA, Chan P, Sandy MS. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann Neurol 1992; 32:xx-xx.
132. Menzie J, Pan C, Prentice H, Wu JY. Taurine and central nervous system disorders. Amino Acid. 2012; [Epub ahead of print].
133. Perfeito R, Cunha-Oliveira T, Cristina Rego A. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease - resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med 2012; Epub ahead of print[PMID: 22967820].
134. Schaffer SW, Azuma J, Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 2009; 87:91-9.[PMID: 19234572].
135. Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 2012; 42:2223-32.[PMID: 21691752].
136. Curtis DR, Watkins JC. The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol Rev 1965; 17:347-91.[PMID: 5321711].
137. Davison AN, Kaczmarek LK. Taurine - a possible transmitter? Nature 1971; 234:107-8.[PMID: 4331550].
138. Kaczmarek LK, Davison AN. The physiological role of taurine. Biochem J 1971; 123:45P-6P.[PMID: 4399554].
139. Kaczmarek LK, Davison AN. Uptake and release of taurine from rat brain slices. J Neurochem 1972; 19:2355-62.[PMID: 4658793].
140. Cunningham R, Miller RF. Taurine; its selective action on neuronal pathways in the rabbit retina. Brain Res 1976; 117:341-5.[PMID: 990921].
141. Burkhardt DA. Proximal negative response of frog retina. J Neurophysiol 1970; 33:405-20.[PMID: 5439344].
142. Cunningham R, Miller RF. Electrophysiological analysis of taurine and glycine action on neurons of the mudpuppy retina. I. Intracellular recording. Brain Res 1980; a197:123-38.[PMID: 6249454].
143. Cunningham RA, Miller RF. Electrophysiological analysis of taurine and glycine action on neurons of the mudpuppy retina. II. ERG, PNR and Muller cell recordings. Brain Res 1980; b197:139-51.[PMID: 6249455].
144. Kudo Y, Tanaka A, Yamada K. Dendrobine, an antagonist of β-alanine, taurine and of presynaptic inhibition in the frog spinal cord. Br J Pharmacol 1983; 78:709-15.[PMID: 6405832].
145. Yarbrough GG, Singh DK, Taylor DA. Neuropharmacological characterization of a taurine antagonist. J Pharmacol Exp Ther 1981; 219:604-13.[PMID: 6795340].
146. Huxtable RJ. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 1989; 32:471-533.[PMID: 2664881].
147. Oja SS, Lähdesmäki P. Is taurine an inhibitory neurotransmitter? Med Biol 1974; 52:138-43.[PMID: 4153628].
148. Haas HL, Hosli L. The depression of brain stem neurons by taurine and its interaction with strychnine and bicuculline. Brain Res 1973; 52:399-402.[PMID: 4700718].
149. Barakat L, Wang D, Bordey A. Carrier-mediated uptake and release of taurine from Bergmann glia in rat cerebellar slices. J Physiol 2002; 541:753-67.[PMID: 12068038].
150. Kinney GA. GAT-3 transporters regulate inhibition in the neocortex. J Neurophysiol 2005; 94:4533-7.[PMID: 16135550].
151. Kudo Y, Akiyoshi E, Akagi H. Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord. Br J Pharmacol 1988; 94:1051-6.[PMID: 2850054].
152. Frosini M, Sesti C, Saponara S, Ricci L, Valoti M, Palmi M, Machetti F, Sgaragli GA. Specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. Br J Pharmacol 2003; 139:487-94.[PMID: 12788808].
153. López-Colomé AM, Fragoso G, Salceda R. Taurine receptors in membranes from retinal pigment epithelium cells in culture. Neuroscience 1991; 41:791-6.[PMID: 1651464].
154. Wu JY, Tang XW, Tsai WH. Taurine receptor: kinetic analysis and pharmacological studies. Adv Exp Med Biol 1992; 315:263-8.[PMID: 1324594].
155. Sung DY, Walthall WW, Derby CD. Identification and partial characterization of putative taurine receptor proteins from the olfactory organ of the spiny lobster. Comp Biochem Physiol B Biochem Mol Biol 1996; 115:19-26.[PMID: 8896329].
156. Anderson PAV, Trapido-Rosenthal HG. Physiological and chemical analysis of neurotransmitter candidates at a fast excitatory synapse in the jellyfish Cyanea capillata (Cnidaria, Scyphozoa). Invert Neurosci 2009; 9:167-73.[PMID: 20013019].
157. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72:101-63.[PMID: 1731369].
158. Lombardini JB. Taurine: Retinal function. Brain Res Brain Res Rev 1991; 16:151-69. [PMID: 1760655].
159. Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen Pharmacol 1995; 26:453-62.[PMID: 7789717].
160. Gordon RE, Heller RF, Del Valle JR, Heller RE. Membrane perturbations and mediation of gap junction formation in response to taurine treatment in normal and injured alveolar epithelia. Exp Lung Res 1989; 15:895-908.[PMID: 2612446].
161. Fukuda T, Ikejima K, Hirose M, Takei Y, Watanabe S, Sato N. Taurine preserves gap junctional intercellular communication in rat hepatocytes under oxidative stress. J Gastroenterol 2000; 35:361-8.[PMID: 10832671].
162. Locke D, Stein T, Davies C, Morris J, Harris AL, Evans WH, Monaghan P, Gusterson B. Altered permeability and modulatory character of connexin channels during mammary gland development. Exp Cell Res 2004; 298:643-60.[PMID: 15265710].
163. Locke D, Kieken F, Tao L, Sorgen PL, Harris AL. Mechanism for modulation of gating of. connexin26- containing channels by taurine. J Gen Physiol 2011; 138:321-39.[PMID: 21844220].
164. Sturman JA. Taurine in the developing rabbit visual system: changes in concentration and axonal transport including a comparison with axonally transported proteins. J Neurobiol 1979; 10:221-37.[PMID: 88503].
165. Sturman JA, Kashdan C. Fate of axonally transported taurine and proteins in the developing rabbit visual system following optic nerve section. Neurochem Res 1980; 5:1127-35.[PMID: 6162111].
166. Olson JE, Martinho E Jr. Regulation of taurine transport in rat hippocampal neurons by hypo-osmotic swelling. J Neurochem 2006; 96:1375-89.[PMID: 16478528].
167. L'Amoreaux W. The role of taurine in the retina. In: Taurine in Health and Disease, 2012: 215-254 Editors: A. El Idrissi and W. L'Amoreaux, pp. 215-254.
168. Horn LW. Measurements of amino acid transport in internally dialyzed giant axons. J Membr Biol 1986; 89:185-92.[PMID: 3701840].
169. McCaman R, Stetzler J. Determination of taurine in individual neurones of Aplysia californica. J Neurochem 1977; 29:739-41.[PMID: 201729].
170. Stevenson PA. Colocalisation of taurine- with transmitter-immunoreactivities in the nervous system of the migratory locust. J Comp Neurol 1999; 404:86-96.[PMID: 9886027].
171. Darnell J, Lodish H, Baltimore D. Molecular cell biology. Scientific American Books, 1990, pp 1105.